期刊文献+

5-甲基-4,5,6,7-四氢噻唑并[5,4-c]吡啶-2-甲酸盐酸盐的合成

Synthesis of 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-formic Acid Hydrochloride
下载PDF
导出
摘要 以N-甲基-4-哌啶酮为起始原料,通过与氰胺、单质硫发生成环反应,合成5-甲基-4,5,6,7-四氢苯并[5,4-c]吡啶-2-胺,再经过取代反应、成盐反应得到2-溴-5-甲基-4,5,6,7-四氢噻唑并[5,4-c]吡啶对甲苯磺酸盐,最后通过游离、成盐合成5-甲基-4,5,6,7-四氢噻唑并[5,4-c]吡啶-2-甲酸盐酸盐。 Using N-methyl-4-piperidone as starting material,5-methyl-4,5,6,7-tetrahydrobenzo[5,4-c]pyridin-2-amine was synthesized by cyclization reaction with cyanamide and elemental sulfur.After substitution reaction and salt formation reaction,2-bromo-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine p-toluenesulfonate was obtained.Finally,5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-formic acid hydrochloride was synthesized through free and salt formation.
作者 李波 沈红 LI Bo;SHEN Hong(Yibin Vocational&Technical College,Yibin,Sichuan 644000,China)
出处 《浙江化工》 CAS 2021年第1期12-14,共3页 Zhejiang Chemical Industry
关键词 N-甲基-4-哌啶酮 成环反应 合成 N-methyl-4-piperidone cyclization reaction synthesis
  • 相关文献

参考文献4

二级参考文献48

  • 1Ohta T, Komoriya S,Yoshino T, et al. Preparation ofN,N'-b\s (heterocyclicacyl) cycloalkanediamine andheterocyclediamine derivatives as inhibitors of activatedblood coagulation factor X (factor Xa): WO, 2003 000657[P]. 2003-01-03. (CA2003,138: 73271).
  • 2Ohta T, Komoriya S,Yoshino T, et al. Preparation ofheterocyclic moiety-containing diamine derivatives as FXainhibitors: WO, 2003 000680 [P], 2003-01-03. (CA 2003,138:89801).
  • 3Mochizuki A, Nagata T. Triamine derivative: WO,2006106963 [P]. 2005-03-31. (CA2006,145: 419128).
  • 4Kawanami K,Ishikawa H, Shoji M. Process for preparationof optically active (15,3^,4/^) -3-amino-4-hydroxy-A^,7V-dimethylcyclohexanecarboxamide derivative salt: WO,2012002538 [P]. 2012-01-05. (CA 2012,156: 122056).
  • 5Sato K, Kubota K. Process for producing optically activecarboxylic acid: WO, 2010067824 [P]. 2010-06-17. (CA2010,153: 36882).
  • 6Yoshikawa K, Yokomizo A, Naito H, et al. Design, synthesis,and SARof cis-1,2-diaminocyclohexane derivatives as potentfactor Xa inhibitors. Part I: Exploration of 5-6fused ringsas alternative SI moieties [J]. Bioorg Med Chem, 2009,17(24):8206-8220.
  • 7Sato K, Kawanami K, Yagi T. Process for the preparation ofoptically active cyclohexane-1,2-diamine derivative from7-oxabicyclo [4.1.0] heptane compound: WO, 2007032498[P]. 2007-03-22. (CA2007,146: 358502).
  • 8Kawanami K. Method for the preparation of optically activediamine derivative: WO, 2010104106 [P]. 2010-09-16. (CA2010,153: 406061).
  • 9Koyama T, Kondo S. Process for the preparation of diaminederivative: WO, 2010104078 [P]. 2010-09-16. (CA 2010,153:382938).
  • 10Suzuki T,Ono M. Crystal of diamine derivative and methodof producing same: WO, 2011115066 [P]. 2011-09-22. (CA2011,155: 467954).

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部